Showing results (681-690 of 718) with videos related to

Sort By:
Pageof 72
Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
A common allele of HLA mediates asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Tasneem Yusufali, Joseph J Sabatino, et al.
The Lancet. HIV|February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research TrialsThumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Viral and Host Mediators of Non-Suppressible HIV-1 ViremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
The Journal of Clinical Investigation|December 1, 2022
Chronic viral coinfections differentially affect the likelihood of developing long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVIDMichael J Peluso, Tyler-Marie Deveau, Sadie E Munter, et al.
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
Pageof 72